Home » Stocks » PetMed Express

PetMed Express, Inc. (PETS)

Stock Price: $31.88 USD 0.26 (0.82%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $32.01 +0.13 (0.41%) Aug 7, 7:59 PM

Stock Price Chart

Key Info

Market Cap 642.90M
Revenue (ttm) 300.34M
Net Income (ttm) 28.28M
Shares Out 20.27M
EPS (ttm) 1.42
PE Ratio 22.45
Forward PE 21.55
Dividend $1.12
Dividend Yield 3.51%

Stock Quote

Trading Day Aug 7, 2020
Last Price $31.88
Previous Close $31.62
Change ($) 0.26
Change (%) 0.82%
Day's Open 31.75
Day's Range 31.35 - 32.40
Day's Volume 684,192
52-Week Range 15.12 - 42.89

More Stats

Market Cap 642.90M
Enterprise Value 556.08M
Earnings Date (est) Oct 26, 2020
Ex-Dividend Date May 14, 2020
Shares Outstanding 20.27M
Float 17.68M
EPS (basic) 1.41
EPS (diluted) 1.42
FCF / Share 1.27
Dividend $1.12
Dividend Yield 3.51%
Earnings Yield 4.45%
FCF Yield 3.94%
Payout Ratio 77.30%
Shares Short 6.36M
Short Ratio 10.02
Short % of Float 37.84%
Beta 0.63
PE Ratio 22.45
Forward PE 21.55
P/FCF Ratio 25.37
PS Ratio 2.14
PB Ratio 4.74
Revenue 300.34M
Operating Income 34.25M
Net Income 28.28M
Free Cash Flow 25.34M
Net Cash 86.82M
Net Cash / Share 4.31
Gross Margin 27.05%
Operating Margin 11.40%
Profit Margin 9.40%
FCF Margin 8.44%
ROA 13.92%
ROE 22.05%
ROIC 105.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 1

Analyst Consensus: Underweight

Price Target

$28.50*
(-10.60% downside)
Low
20.0
Current: $31.88
High
37.0
Target: 28.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue284283274249235229233228238232
Revenue Growth0.25%3.51%9.88%6.18%2.31%-1.71%2.44%-4.37%2.85%-
Gross Profit81.2595.3197.8179.3176.3076.2777.6277.1280.1783.96
Operating Income30.9846.1752.1437.4832.3927.6128.2227.0126.0233.02
Net Income25.8537.7437.2823.8220.5717.4517.9717.1716.6620.87
Shares Outstanding20.0420.4620.3520.2320.1220.0219.9019.9320.6122.51
Earnings Per Share1.291.841.821.171.020.870.900.860.800.92
EPS Growth-29.89%1.1%55.56%14.71%17.24%-3.33%4.65%7.5%-13.04%-
Dividend Per Share1.081.060.850.760.720.680.660.600.530.48
Dividend Growth1.89%24.71%11.84%5.56%5.88%3.03%10%14.29%10.53%-
Operating Cash Flow38.8445.1437.3847.2021.0532.0413.5113.2920.3930.11
Capital Expenditures-2.31-0.62-0.70-10.60-20.13-0.92-0.05-0.63-0.71-0.67
Free Cash Flow36.5344.5236.6836.600.9231.1313.4612.6619.6929.44
Cash & Equivalents10410177.9458.7337.6451.2033.8433.6557.1559.78
Net Cash / Debt10410177.9458.7337.6451.2033.8433.6557.1559.78
Assets15515413511390.2882.8578.3873.1891.06106
Liabilities25.3119.7519.1119.447.087.428.169.179.889.28
Book Value13013511693.3783.2075.4470.2264.0181.1897.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PetMed Express, Inc.
Country United States
Employees 214
CEO Menderes Akdag

Stock Information

Ticker Symbol PETS
Stock Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Unique Identifier NASDAQ: PETS

Description

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.